Login / Signup

Patterns of chemotherapy use in muscle-invasive bladder cancer in a tertiary centre.

Kylie Yen-Yi LimKevin ChuNieroshan RajarubendraJames HuangDavid PookPaul ManoharMatthew HarperScott DonnellanWeranja Ranasinghe
Published in: Bladder (San Francisco, Calif.) (2023)
The majority of patients undergoing RC for MIBC received AC compared to NAC, reflecting the real-world challenge of NAC uptake. This highlights the need for ongoing improvements in selection and usage of NAC and less reliance of AC utilization post RC.
Keyphrases
  • transcription factor
  • muscle invasive bladder cancer
  • patients undergoing
  • genome wide analysis
  • locally advanced
  • squamous cell carcinoma
  • radiation therapy